Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-20

Clinical Trial Update: Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)

View source ↗

Summary

This clinical trial update reports the completion of a natural history study in patients with X-linked retinitis pigmentosa associated with RPGR mutations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: MeiraGTx UK II Ltd | Conditions: Retinitis Pigmentosa | Status: COMPLETED